Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Lisata Therapeutics Inc’s stock clocked out at $2.47, down -7.49% from its previous closing price of $2.67. In other words, the price has decreased by -$7.49 from its previous closing price. On the day, 1.59 million shares were traded. LSTA stock price reached its highest trading level at $2.6053 during the session, while it also had its lowest trading level at $2.45.
Ratios:
To gain a deeper understanding of LSTA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.77 and its Current Ratio is at 5.77. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LSTA now has a Market Capitalization of 21627192 and an Enterprise Value of -549808. For the stock, the TTM Price-to-Sale (P/S) ratio is 20.21 while its Price-to-Book (P/B) ratio in mrq is 1.01. Its current Enterprise Value per Revenue stands at -0.514 whereas that against EBITDA is 0.026.
Stock Price History:
The Beta on a monthly basis for LSTA is 1.07, which has changed by -0.08561641 over the last 52 weeks, in comparison to a change of 0.15566266 over the same period for the S&P500. Over the past 52 weeks, LSTA has reached a high of $4.20, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is 2.31%, while the 200-Day Moving Average is calculated to be 0.00%.
Shares Statistics:
It appears that LSTA traded 38.46K shares on average per day over the past three months and 61580 shares per day over the past ten days. A total of 8.63M shares are outstanding, with a floating share count of 7.19M. Insiders hold about 17.83% of the company’s shares, while institutions hold 8.94% stake in the company. Shares short for LSTA as of 1760486400 were 19558 with a Short Ratio of 0.51, compared to 1757894400 on 15493. Therefore, it implies a Short% of Shares Outstanding of 19558 and a Short% of Float of 0.27.
Earnings Estimates
. The current rating of Lisata Therapeutics Inc (LSTA) reflects the combined expertise of 2.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.62, with high estimates of -$0.5 and low estimates of -$0.74.
Analysts are recommending an EPS of between -$2.09 and -$2.4 for the fiscal current year, implying an average EPS of -$2.23. EPS for the following year is -$1.02, with 2.0 analysts recommending between -$0.96 and -$1.09.
